Beachbody Company, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Beachbody Company, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	756	864	874	692	527	419	252
Cost of revenue	210	250	329	323	204	131	67.9
Gross profit	545	614	545	370	323	287	184
Research and development	4.6	4.6	4.6	4.4	2.7	1.6	1.7
Selling and marketing	384	464	548	360	282	200	93.6
General and administrative	56.9	64.8	79.7	78.4	57.9	49.2	39.9
Operating expenses	527	620	842	573	464	354	178
Operating income	18.9	-6.3	-297	-203	-141	-66.2	5.53
Interest expense	0.79	0.53	0.54	3.37	8.87	6.88	4.98
Interest income					1.9	1.2	1.1
Other non-operating income	0.81	0.67	3.2	0.96	1.75	2.92	0.86
Pre-tax income	18.9	-6.16	-244	-197	-153	-71.4	-2.74
Income tax	-13.4	15.3	-15.5	-3.05	0.04	0.24	0.13
Net income	32.3	-21.4	-228	-194	-153	-71.6	-2.86
EBITDA	63.5	38	-238	-128	-101	-34.8	14.2
EPS, basic	7.02	-4.51	-41.61	-31.58	-24.47	-10.51	-0.41
EPS, diluted	6.02	-4.51	-41.61	-31.58	-24.47	-10.51	-0.41
Shares, basic (weighted)	4.71	4.78	5.49	6.15	6.24	6.82	6.97
Shares, diluted (weighted)	5.51	4.78	5.49	6.15	6.24	6.82	6.97

Balance sheet

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	41.6	56.8	104	80.1	33.4	20.2	39
Receivables		0.86	1.23	0.87	1.27	1.45	1.14
Inventory		65.4	133	54.1	25	16.3	9.41
Other current assets		38.2	43.7	39.2	45.9	28.9	4.34
Total current assets		169	299	186	119	78.7	63.8
Property, plant and equipment		80.2	113	74.1	45.1	12.7	8.52
Lease right-of-use assets		32.9	6.4	5	3.1	3.1	1.6
Goodwill	7.66	19	125	125	85.2	65.2	65.2
Intangible assets		21.1	46.4	8.2	0	0
Long-term investments		300
Other non-current assets		14.2	7.65	9.51	2.92	2.71	1.59
Total assets		356	638	443	277	175	147
Accounts payable		29	48.4	17.9	10.7	9.53	5.3
Accrued liabilities		80	74.5	64.4	42.1	25	18.4
Deferred revenue		97.5	107	95.6	97.2	77.3	56.9
Short-term debt				1.25	8.07	9.5	1.06
Total current liabilities		220	236	185	165	128	86.6
Long-term debt				39.7	21.5	9.67	22.6
Other non-current liabilities		2.1	8.01	3.98	5.95	7.11	5.82
Total liabilities		257	252	232	194	146	116
Total debt				49.4	35.1	21.6	25
Paid-in capital		96.1	610	631	655	672	678
Retained earnings		3.34	-225	-419	-572	-644	-646
Other comprehensive income		-0.2	-0.02	0.04	-0.02	-0.05	-0.05
Shareholders' equity	87.4	99.3	385	212	82.8	28.2	31.3
Total equity	87.4	99.3	385	212	82.8	28.2	31.3
Total liabilities and equity		356	638	443	277	175	147

Cash flow statement

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	32.3	-21.4	-228	-194	-153	-71.6	-2.86
Depreciation and amortization	44.7	44.3	59.6	74.8	39.6	31.4	8.68
Stock-based compensation	3.58	5.4	16.4	17.6	23.9	17.1	5.62
Deferred income tax	-14.5	-15.6	15.9	2.96	0.19	0.01	0
Change in inventory	-8.42	-27.8	-74.3	41.5	17.5	4.38	5.4
Change in payables	2.05	10.6	8.31	-26.7	-7.1	-0.91	-4.19
Cash from operations	42	61.4	-215	-47.2	-22.5	2.56	21.8
Capital expenditures	-23.8	-37.9	-77.9	-26.5	-6.58	-4.54	-4.4
Acquisitions	-6.47	1.25	-37.3
Cash from investing	-30.3	-46.7	-125	-26.5	-10.8	1.06	-4.4
Stock issued			4.68	3.16	4.91		0.52
Cash from financing	-32.1	0.17	391	47.6	-13.7	-15.9	1.03
Exchange rate effect	0.41	0.35	0.02	-0.86	0.4	-0.97	0.45
Net change in cash	-19.9	15.3	50.2	-27	-46.7	-13.2	18.8
Free cash flow	18.2	23.5	-293	-73.7	-29.1	-1.98	17.4
Interest paid	0.63	0.21	0.47	2.08	5.39	3.56	2.64
Income taxes paid	1.05	0.33	0.39	0.39	0.01	0.23

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.74 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	73.3%	Gross profit / revenue.
Operating margin	8.2%	Operating income / revenue.
EBITDA margin	11.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.7%	Pre-tax income / revenue.
Net margin	5.7%	Net income / revenue.
FCF margin	3.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.0%	Cash from operations / revenue.
Effective tax rate	1.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	33.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	9.1%	Net income / average total assets.
Return on invested capital (ROIC)	59.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	2.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.5%	Capital expenditures / revenue.
D&A / revenue	3.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-39.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-28.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-21.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-36.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-20.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-21.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-17.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	748.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-18.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-5.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	11.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-47.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-20.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-30.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-16.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	7.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.79x	Current assets / current liabilities.
Quick ratio	0.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.44x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.67x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.3%	Total debt / total assets.
Liabilities / assets	72.8%	Total liabilities / total assets.
Net debt	-$7.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.29x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.31x	Operating income / interest expense.
Working capital	-$15.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	47.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$28.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.61x	Revenue / average total assets.
Fixed asset turnover	37.7x	Revenue / average property, plant and equipment.
Inventory turnover	4.66x	Cost of revenue / average inventory.
Days inventory	78 days	365 x average inventory / cost of revenue.
Receivables turnover	163x	Revenue / average receivables.
Days sales outstanding	2 days	365 x average receivables / revenue.
Days payables	43 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	38 days	Days inventory + days sales outstanding - days payables.
FCF conversion	60.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	30.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.58	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$27.75	Revenue / diluted weighted shares.
FCF per share	$0.96	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.38	Cash from operations / diluted weighted shares.
Book value per share	$4.70	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$3.54	Tangible book value / shares outstanding.
Cash per share	$4.10	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$34.4M	Share price x shares outstanding.
Enterprise value	$27.0M	Market cap + total debt - cash - short-term investments.
P/E	2.76x	Market cap / net income. Only when net income is positive.
P/S	0.16x	Market cap / revenue.
P/B	0.92x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	4.55x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.16x	Market cap / cash from operations, when positive.
EV/Sales	0.12x	Enterprise value / revenue.
EV/EBIT	1.50x	Enterprise value / operating income, when both are positive.
EV/EBITDA	1.04x	Enterprise value / EBITDA, when both are positive.
EV/FCF	3.57x	Enterprise value / free cash flow, when both are positive.
FCF yield	22.0%	Free cash flow / market cap.
Earnings yield	36.2%	Net income / market cap (the inverse of P/E).

What was Beachbody Company, Inc.'s revenue in fiscal 2025?

Beachbody Company, Inc. reported revenue of $251.7M for fiscal 2025, 39.9% lower than the year before.

Was Beachbody Company, Inc. profitable in fiscal 2025?

No. It reported a net loss of $2.9M.

How much free cash flow did Beachbody Company, Inc. generate in fiscal 2025?

Cash from operations of $21.8M minus capital expenditures of $4.4M left free cash flow of $17.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Beachbody Company, Inc.